Company profile
Aerium Therapeutics SA
Aerium is building a pipeline of biologics and small molecule antivirals focused on protecting the world against pandemic and epidemic threats.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". Register for more services
Partners
Contributors
